HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
As part of National Biomanufacturing Day 2025, HTL Biotechnology inaugurates a new production line dedicated to Hyaluronic Acid.
Press releases
June 5, 2025
HTL Biotechnology inaugurates a new production line dedicated to sterile Hyaluronic Acid
On the occasion of National Bioproduction and Biomedicines Day (JNBB), which enjoys the high patronage of the President of the French Republic, HTL Biotechnology confirms its position as a global leader in the development and production of pharmaceutical-grade biopolymers, by inaugurating a new production unit dedicated to sterile hyaluronic acid at its Javené (Ille-et-Vilaine) site, a true flagship of French biomanufacturing.
To see our most recent news,
follow us on LinkedIn
Read more
news from us
-
Articles July 23, 20252024 CSR Report is now available!
We’re pleased to share our second CSR report, highlighting the actions and commitments we carried out throughout 2024.
-
Articles June 12, 2025Strong Presence at ISHAS Congress 2025 in the USA
A Global Scientific Gathering Dedicated to Hyaluronic Acid Innovation.
-
Press releases May 27, 2025HTL Biotechnology supports National Biomedicines manufacturing Day
HTL Biotechnology is proud to support National Biomedicines manufacturing Day, which will take place on June 5, 2025.